|
|
See Category: Diseases of the eye and adnexa
See Header: Other disorders of lacrimal gland
ICD-10 (CM) Code and Descriptor
|
H04.19 |
Other specified disorders of lacrimal gland
|
H0419 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 37.93%
|
14.66%
|
7.76%
|
11.21%
|
6.03%
|
6.03%
|
3.45%
|
2.59%
|
0.86%
|
0.86%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for H04.19*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
7
|
13
|
|
88185
|
FLOWCYTOMETRY/TC ADD-ON |
5
|
52
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
5
|
435
|
|
70481
|
CT ORBIT/EAR/FOSSA W/DYE |
5
|
5
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
4
|
7
|
|
J2405
|
ONDANSETRON HCL INJECTION |
3
|
12
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
3
|
4
|
|
J3010
|
FENTANYL CITRATE INJECTION |
3
|
5
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
3
|
16
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
3
|
37
|
|
88365
|
INSITU HYBRIDIZATION (FISH) |
3
|
3
|
|
88184
|
FLOWCYTOMETRY/ TC 1 MARKER |
3
|
3
|
|
J0131
|
INJ, ACETAMINOPHEN (NOS) |
3
|
300
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
3
|
12
|
|
68510
|
BIOPSY OF TEAR GLAND |
2
|
2
|
|
86235
|
NUCLEAR ANTIGEN ANTIBODY |
2
|
2
|
|
80053
|
COMPREHEN METABOLIC PANEL |
2
|
2
|
|
86140
|
C-REACTIVE PROTEIN |
2
|
2
|
|
88239
|
TISSUE CULTURE TUMOR |
2
|
2
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
2
|
2
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
H04.19 related to the following DRG Codes:
124-125
|
